Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gardasil: from bench, to bedside, to blunder.

× No keyword cloud information.

17 in total

1. Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon.

Authors: Richard G Wamai; Claudine Akono Ayissi; Geofrey O Oduwo; Stacey Perlman; Edith Welty; Simon Manga; Javier Gordon Ogembo
Journal: J Community Health Date: 2012-10

2. Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.

Authors: Cornelia L Trimble; Rachael A Clark; Christopher Thoburn; Nicole C Hanson; Jodie Tassello; Denise Frosina; Ferdynand Kos; Jessica Teague; Ying Jiang; Nicole C Barat; Achim A Jungbluth
Journal: J Immunol Date: 2010-10-29 Impact factor: 5.422

3. Correlates of human papillomavirus vaccine coverage: a state-level analysis.

Authors: Jennifer L Moss; Paul L Reiter; Noel T Brewer
Journal: Sex Transm Dis Date: 2015-02 Impact factor: 2.830

4. Contribution of communication inequalities to disparities in human papillomavirus vaccine awareness and knowledge.

Authors: Emily Z Kontos; Karen M Emmons; Elaine Puleo; K Viswanath
Journal: Am J Public Health Date: 2012-02-16 Impact factor: 9.308

5. U.S. geographic distribution of prevaccine era cervical cancer screening, incidence, stage, and mortality.

Authors: Marie-Josèphe Horner; Sean F Altekruse; Zhaohui Zou; Louise Wideroff; Hormuzd A Katki; David G Stinchcomb
Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-01-25 Impact factor: 4.254

6. HPV vaccine acceptance, utilization and expected impacts in the U.S.: Where are we now?

Authors: Amanda F Dempsey; Divya A Patel
Journal: Hum Vaccin Date: 2010-09-16

7. Human papillomavirus vaccine uptake among 9- to 17-year-old girls: National Health Interview Survey, 2008.

Authors: Charlene A Wong; Zahava Berkowitz; Christina G Dorell; Rebecca Anhang Price; Jennifer Lee; Mona Saraiya
Journal: Cancer Date: 2011-06-20 Impact factor: 6.860

8. Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial.

Authors: Cornelia L Trimble; Matthew P Morrow; Kimberly A Kraynyak; Xuefei Shen; Michael Dallas; Jian Yan; Lance Edwards; R Lamar Parker; Lynette Denny; Mary Giffear; Ami Shah Brown; Kathleen Marcozzi-Pierce; Divya Shah; Anna M Slager; Albert J Sylvester; Amir Khan; Kate E Broderick; Robert J Juba; Timothy A Herring; Jean Boyer; Jessica Lee; Niranjan Y Sardesai; David B Weiner; Mark L Bagarazzi
Journal: Lancet Date: 2015-09-17 Impact factor: 79.321

9. Prevalence of anogenital warts among participants in private health plans in the United States, 2003-2010: potential impact of human papillomavirus vaccination.

Authors: Elaine W Flagg; Robert Schwartz; Hillard Weinstock
Journal: Am J Public Health Date: 2013-06-13 Impact factor: 9.308

10. Different models of HPV vaccine decision-making among adolescent girls, parents, and health-care clinicians in New Mexico.

Authors: Christina M Getrich; Lisa M Broidy; Erin Kleymann; Deborah L Helitzer; Alberta S Kong; Andrew L Sussman
Journal: Ethn Health Date: 2013-11-21 Impact factor: 2.772